Table 4.

Mean Latencies (Days) From Start of NOAC Treatment at Different Time Points After Stroke Onset

Time Intervals	Mean	Quartile 1	Median	Quartile 3
Combined (ischemic and hemorrhagic) outcome events, d
<3	26.4	3.25	20.5	53.0
3–7	25.9	7.75	17.0	35.5
8–14	33.7	5.5	13.0	64.5
≥15	33.9	11.0	29.0	51.5
Overall combined outcomes	29.2	6.75	17.0	52.75
Ischemic outcome events, d
<3	28.8	4.0	31.0	52.0
3–7	32.4	17.0	20.0	43.5
8–14	30.0	5.5	11.0	45.0
≥15	26.3	20.0	29.0	34.0
Overall ischemic outcomes	30.4	12.0	22.5	45.75
Hemorrhagic outcome events, d
<3	31.0	7.75	33.0	56.25
3–7	15.9	5.0	7.0	12.0
8–14	35.1	6.25	27.5	59.75
≥15	33.8	11.0	11.0	64.0
Overall hemorrhagic outcomes	28.5	5.5	11.0	56.25

NOACs indicates non–vitamin K oral anticoagulants.